Article No
LS-C112525-0.1
SELL / L-Selectin / CD62L
CD62L antibody LS-C112525 is an FITC-conjugated rat monoclonal antibody to mouse CD62L (SELL / L-Selectin). Validated for Flow, Func, ICC, IHC and IP.
Antibodies Primary
Specifications
| NCBI Number | 6402 |
| Application | FA, FC, ICC, IHC, IP |
| Article No | LS-C112525-0.1 |
| Country Availability | SE, FI, DK, NO, FO, GL |
| Clone | MEL-14 |
| Clone Type | monoclonal |
| Concentration | 0.5 mg/ml |
| Conjugation | FITC |
| Description | CD62L antibody LS-C112525 is an FITC-conjugated rat monoclonal antibody to mouse CD62L (SELL / L-Selectin). Validated for Flow, Func, ICC, IHC and IP. |
| Supplier | LifeSpan Biosciences |
| Entrez Gene ID | 6402 |
| Gene Symbol | SELL |
| Immunogen | C3H/eb mouse B cell lymphoma 38C-13. |
| Isotype | IgG2a |
| Notes | CD62L antibody LS-C112525 is an FITC-conjugated rat monoclonal antibody to mouse CD62L (SELL / L-Selectin). Validated for Flow, Func, ICC, IHC and IP. |
| Alias Names | SELL, CD62L, CD62L antigen, LAM-1, LAM1, LECAM1, LEU8, Leukocyte adhesion molecule 1, Lyam-1, LSEL, gp90-MEL, HLHRc, PLNHR, L-selectin, Leu-8, Selectin L, LNHR, LYAM1, Lymph node homing receptor, Lymphocyte adhesion molecule 1, TQ1, Pln homing receptor, CD26L |
| Product Type | Antibodies Primary |
| Protocol | Suggested working concentration is 6 ug/ml. Indicated dilution is recommended starting point for use of this product. Working concentrations should be determined by the investigator. |
| Purification | Protein G purified |
| Shipping Information | RT |
| Size | 0.1 mg |
| Source / Host | rat |
| Species Reactivity | mouse |
| Storage | 4°C |
| Substrate / Buffer | PBS, pH 7.4, 15 mM Sodium Azide |
| Technical Specifications | The rat monoclonal antibody MEL-14 reacts with mouse CD62L (L-selectin), a 75 kDa single chain type I glycoprotein expressed on most peripheral blood B lymphocytes, T lymphocytes, monocytes and granulocytes; it is also present on a subset of NK cells and certain hematopoietic malignant cells. |
| Product Page Updated | 2024-04-12T06:35:05.844Z |
